Woo; Byoung Young

Patent Applications and Registrations

Patent applications and USPTO patent grants for Woo; Byoung Young.The latest application filed is for "nanoemulsion cosmetic composition and process for preparing same".

Company Profile

9.11.18

Woo; Byoung Young - Yongin-si KR
Woo; Byoung Young - Gyeonggi-do KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition for preventing or treating sleep disorders Grant 11,382,900 - Choi , et al. July 12, 2	2022-07-12
Nanoemulsion Cosmetic Composition And Process For Preparing Same App 20220125692 - WOO; Byoung Young ; et al.	2022-04-28
Ginseng Powder, Cosmetic Composition Comprising Same And Preparation Method Thereof App 20220125709 - WOO; Byoung Young ; et al.	2022-04-28
Sol-gel Composition App 20220000775 - CHO; Wonkyung ; et al.	2022-01-06
Pharmaceutical Composition Containing (r)-n-[1-(3,5-difluoro-4-methanesulfonylamino-phenyl)-ethyl]-3-(2-propyl-- 6-trifluoromethylpyridin-3-yl)-acrylamide And Method For Inhibiting Crystal Formation Thereof App 20200405701 - CHOI; Joonho ; et al.	2020-12-31
Method for preparing (R)-N-[4-(1-amino-ethyl)-2,6-difluoro-phenyl]-methanesulfonamide Grant 10,858,315 - Woo , et al. December 8, 2	2020-12-08
Pharmaceutical Composition Containing (r)-n-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6- -trifluoromethy App 20200215040 - CHOI; Joon Ho ; et al.	2020-07-09
Adamantane derivative compound Grant 10,696,611 - Joo , et al. June 30, 2	2020-06-30
Composition For Preventing Or Treating Atopic Dermatitis App 20200197379 - CHOI; Gyeyoung ; et al.	2020-06-25
Composition For Preventing Or Treating Sleep Disorders App 20200197378 - CHOI; Gyeyoung ; et al.	2020-06-25
Method For Preparing (r)-n-[4-(1-amino-ethyl)-2,6-difluoro-phenyl]-methanesulfonamide App 20200031766 - WOO; Byoung Young ; et al.	2020-01-30
Chiral resolution method of N-[4-(1-aminoethyl)-phenyl]-sulfonamide derivatives Grant 10,479,763 - Woo , et al. Nov	2019-11-19
Chiral Resolution Method Of N-[4-(1-aminoethyl)-phenyl]-sulfonamide Derivatives App 20170342027 - WOO; Byoung Young ; et al.	2017-11-30
Novel Adamantane Derivative Compound App 20170283347 - JOO; Yung Hyup ; et al.	2017-10-05
Novel Pseudoceramide Compound And Production Method For Same App 20150290099 - Woo; Byoung Young ; et al.	2015-10-15
Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same Grant 8,691,855 - Woo , et al. April 8, 2	2014-04-08
Novel Compounds, Isomer Thereof, Or Pharmaceutically Acceptable Salts Thereof As Vanilloid Receptor Antagonist; And Pharmaceutical Compositions Containing The Same App 20140011881 - SHIN; Song Seok ; et al.	2014-01-09
Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same Grant 8,557,872 - Shin , et al. October 15, 2	2013-10-15
2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-.alpha. Grant 8,013,187 - Kim , et al. September 6, 2	2011-09-06
Novel Compounds, Isomer Thereof, Or Pharmaceutically Acceptable Salts Thereof As Vanilloid Receptor Antagonist And Pharmaceutical Compositions Containing The Same App 20110152318 - Woo; Byoung Young ; et al.	2011-06-23
Novel Compounds, Isomer Thereof, Or Pharmaceutically Acceptable Salts Thereof As Vanilloid Receptor Antagonist; And Pharmaceutical Compositions Containing The Same App 20110015230 - Shin; Song Seok ; et al.	2011-01-20
Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same Grant 7,858,621 - Kim , et al. December 28, 2	2010-12-28
Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same Grant 7,763,657 - Kim , et al. July 27, 2	2010-07-27
Composition For Transdermal Absorption And Formulation Comprising A Polymeric Matrix Formed Therefrom App 20090117192 - Ah; Young Chang ; et al.	2009-05-07
Novel Compounds, Isomer Thereof, Or Pharmaceutically Acceptable Salts Thereof As Vanilloid Receptor Antagonist; And Pharmaceutical Compositions Containing The Same App 20090105258 - Kim; Hee-Doo ; et al.	2009-04-23
2-Cyclopenten-1-One Oxime Derivatives Inhibiting Production of TNF-Alpha App 20090036501 - Kim; Yeonjoon ; et al.	2009-02-05
Novel Compounds, Isomer Thereof, Or Pharmaceutically Acceptable Salts Thereof As Vanilloid Receptor Antagonist; And Pharmaceutical Compositions Containing The Same App 20080312234 - KIM; Sun-Young ; et al.	2008-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.